These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1686758)

  • 21. Lack of effect of intranigral administration of a dopamine analogue, (+/-)-3-(3-hydroxyphenyl)-N,n-propylpiperidine [(+/-)-3-PPP], on nigrostriatal dopamine neurones.
    Kelly E; Jenner P; Marsden CD
    Neurosci Lett; 1985 May; 56(1):57-62. PubMed ID: 4011049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
    Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
    J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 5-HT3 receptor antagonists LY 277359 and granisetron potentiate the suppressant action of apomorphine on the basal firing rate of ventral tegmental dopamine cells.
    Minabe Y; Ashby CR; Schwartz JE; Wang RY
    Eur J Pharmacol; 1991 Dec; 209(3):143-50. PubMed ID: 1665793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated reserpine treatment alters firing pattern and responses of substantia nigral dopamine neurons.
    Sun BC; Huang KX; Jin GZ
    Eur J Pharmacol; 1993 Feb; 231(3):331-8. PubMed ID: 8095463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamine neurons: an electrophysiological study.
    Tajiri K; Emori K; Murata M; Tanaka K; Suzuki M; Uehara T; Sumiyoshi T; Ashby CR; Kurachi M
    Synapse; 2001 Jun; 40(4):275-81. PubMed ID: 11309843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study.
    Minabe Y; Emori K; Toor A; Stutzmann GE; Ashby CR
    Synapse; 1996 Jan; 22(1):35-45. PubMed ID: 8822476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study.
    Minabe Y; Matsuno K; Ashby CR
    Synapse; 1999 Aug; 33(2):129-40. PubMed ID: 10400891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiological evaluation of a partial agonist of dopamine receptors.
    Piercey MF; Hoffmann WE; Vogelsang GD; Travis M
    J Pharmacol Exp Ther; 1987 Oct; 243(1):391-6. PubMed ID: 3668865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
    Gronier B; Debonnel G
    Eur J Pharmacol; 1999 Mar; 368(2-3):183-96. PubMed ID: 10193654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of dopaminergic neuron firing by heterogeneous dopamine autoreceptors in the substantia nigra pars compacta.
    Jang JY; Jang M; Kim SH; Um KB; Kang YK; Kim HJ; Chung S; Park MK
    J Neurochem; 2011 Mar; 116(6):966-74. PubMed ID: 21073466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities.
    Kreiss DS; Bergstrom DA; Gonzalez AM; Huang KX; Sibley DR; Walters JR
    Eur J Pharmacol; 1995 Apr; 277(2-3):209-14. PubMed ID: 7493610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. gamma-Hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB-receptors.
    Engberg G; Nissbrandt H
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):491-7. PubMed ID: 8114948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zetidoline, a novel neuroleptic, activates nigral dopaminergic neurons in rats.
    Mereu G; Fanni B; Collu M; Diena A; Glasser A
    Life Sci; 1985 Feb; 36(5):459-64. PubMed ID: 2857469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
    Blackburn TP; Minabe Y; Middlemiss DN; Shirayama Y; Hashimoto K; Ashby CR
    Synapse; 2002 Dec; 46(3):129-39. PubMed ID: 12325040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential electrophysiological effects of 3-PPP and its enantiomers on dopamine autoreceptors and postsynaptic receptors.
    Bergstrom DA; Carlson JH; Bromley SD; Jackson DM; Walters JR
    Eur J Pharmacol; 1986 May; 124(1-2):75-84. PubMed ID: 3720847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Firing properties of substantia nigra dopaminergic neurons in freely moving rats.
    Freeman AS; Meltzer LT; Bunney BS
    Life Sci; 1985 May; 36(20):1983-94. PubMed ID: 3990520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (+/-)-3,4-Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons.
    Kelland MD; Freeman AS; Chiodo LA
    Eur J Pharmacol; 1989 Oct; 169(1):11-21. PubMed ID: 2574685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat.
    Fà M; Mereu G; Ghiglieri V; Meloni A; Salis P; Gessa GL
    Synapse; 2003 Apr; 48(1):1-9. PubMed ID: 12557266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.